Monday, March 1, 2021

Cipla gets USFDA nod for migraine drug

Cipla gets USFDA nod for migraine drug The newly approved product is a generic therapeutic equivalent version of GlaxoSmithKline#39;s Imitrex Nasal Spray.

from Moneycontrol Business News https://ift.tt/2OhK3rC

No comments:

Post a Comment

D-St surges 1% on reports govt to cut tax on foreign bond bets

Indian stock markets surged on Thursday. The Nifty and Sensex saw significant gains. This rise was driven by reports of a potential tax cut ...